Immunogenicity and protective efficacy against

Animals Antibodies, Bacterial / blood Female Flagellin / genetics Glycoconjugates / administration & dosage Immunization Immunogenicity, Vaccine Immunoglobulin G / blood Mice Mice, Inbred BALB C Polysaccharides, Bacterial / administration & dosage Salmonella Infections / prevention & control Salmonella Vaccines / administration & dosage Serogroup
None Group C O polysaccharide conjugate flagellin vaccine

Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
2019
Historique:
pubmed: 7 6 2018
medline: 3 3 2020
entrez: 7 6 2018
Statut: ppublish

Résumé

Nontyphoidal

Identifiants

DOI: 10.1080/21645515.2018.1483808 PMID: 29873578 PMC: PMC6663135
pubmed: 29873578
doi: 10.1080/21645515.2018.1483808
pmc: PMC6663135
doi:

Substances chimiques

Antibodies, Bacterial 0
Glycoconjugates 0
Immunoglobulin G 0
Polysaccharides, Bacterial 0
Salmonella Vaccines 0
Flagellin 12777-81-0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1436-1444

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI109776
Pays : United States

Références

Hum Vaccin Immunother. 2012 Apr;8(4):494-8
pubmed: 22370510
J Biol Chem. 1949 Aug;180(1):249-61
pubmed: 18133390
Lancet. 2017 Dec 2;390(10111):2472-2480
pubmed: 28965718
Infect Immun. 2009 Mar;77(3):1128-36
pubmed: 19114545
PLoS One. 2016 Mar 21;11(3):e0151875
pubmed: 26998925
N Engl J Med. 2001 Apr 26;344(17):1263-9
pubmed: 11320385
Clin Infect Dis. 2010 Mar 15;50(6):882-9
pubmed: 20158401
Protein Expr Purif. 2014 Oct;102:1-7
pubmed: 25050462
Nat Rev Immunol. 2009 Mar;9(3):213-20
pubmed: 19214194
Infect Immun. 1992 Nov;60(11):4679-86
pubmed: 1383154
PLoS Negl Trop Dis. 2017 Apr 7;11(4):e0005493
pubmed: 28388624
Vaccine. 2011 Jul 12;29(31):4881-90
pubmed: 21549783
J Infect Dis. 2008 Jul 1;198(1):109-14
pubmed: 18462137
Clin Vaccine Immunol. 2016 Sep 06;23(9):737-45
pubmed: 27413069
Am J Vet Res. 2011 Feb;72(2):239-47
pubmed: 21281199
Infect Immun. 2011 Oct;79(10):4240-9
pubmed: 21807909
Infect Immun. 1981 May;32(2):490-6
pubmed: 6166555
Am J Trop Med Hyg. 2018 Feb;98(2):589-594
pubmed: 29280425
Infect Immun. 2011 Oct;79(10):4175-85
pubmed: 21807911
Infect Immun. 2015 Sep;83(9):3722-31
pubmed: 26169269
Vaccine. 1996 Apr;14(5):435-8
pubmed: 8735556
Clin Infect Dis. 2004 Apr 15;38 Suppl 3:S149-56
pubmed: 15095184
Clin Vaccine Immunol. 2014 May;21(5):712-21
pubmed: 24623629

Auteurs

Ofir Schuster (O)

a Center for Vaccine Development and Global Health , University of Maryland School of Medicine , Baltimore , MD , USA.
b Department of Infectious Diseases , Israel Institute for Biological Research , Ness-Ziona , Israel.

Khandra T Sears (KT)

a Center for Vaccine Development and Global Health , University of Maryland School of Medicine , Baltimore , MD , USA.

Girish Ramachandran (G)

a Center for Vaccine Development and Global Health , University of Maryland School of Medicine , Baltimore , MD , USA.
c Center for Biologics Evaluation and Research , U.S. Food and Drug Administration , Silver Spring , MD , USA.

Fabien J Fuche (FJ)

a Center for Vaccine Development and Global Health , University of Maryland School of Medicine , Baltimore , MD , USA.

Brittany Curtis (B)

a Center for Vaccine Development and Global Health , University of Maryland School of Medicine , Baltimore , MD , USA.

Sharon M Tennant (SM)

a Center for Vaccine Development and Global Health , University of Maryland School of Medicine , Baltimore , MD , USA.

Raphael Simon (R)

a Center for Vaccine Development and Global Health , University of Maryland School of Medicine , Baltimore , MD , USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Meal Timing and Anthropometric and Metabolic Outcomes: A Systematic Review and Meta-Analysis.

Hiu Yee Liu, Ashley A Eso, Nathan Cook et al.
1.00
Humans Meals Time Factors Female Adult

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Immunogenicity and protective efficacy against
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Anticorps antibactériens › Immunogenicity and protective efficacy against
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines bactériennes › Flagelline › Immunogenicity and protective efficacy against
questionsmedicales.fr › Glucides › Glycoconjugués › Immunogenicity and protective efficacy against
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Prévention primaire › Immunisation › Immunogenicity and protective efficacy against
questionsmedicales.fr › Phénomènes du système immunitaire › Immunogénicité des vaccins › Immunogenicity and protective efficacy against
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Isotypes des immunoglobulines › Immunoglobuline G › Immunogenicity and protective efficacy against
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Immunogenicity and protective efficacy against
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Lignées consanguines de souris › Souris de lignée BALB C › Immunogenicity and protective efficacy against
questionsmedicales.fr › Facteurs biologiques › Antigènes › Antigènes bactériens › Polyosides bactériens › Immunogenicity and protective efficacy against
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Enterobacteriaceae › Salmonelloses › Immunogenicity and protective efficacy against
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antibactériens › Vaccins antisalmonella › Immunogenicity and protective efficacy against
questionsmedicales.fr › Phénomènes génétiques › Phénotype › Sérogroupe › Immunogenicity and protective efficacy against